NYSE · SI
Healthcare · Medical - Specialties
$19.14
Down-$0.46 (-2.35%)
Updated Oct 7, 2026, 6:28 AM
SID Score
4.8/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · SI
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
SI closed at $19.14 after 21 trading sessions, down 4.25% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $19.56 | $19.91 | $19.03 | $19.14 | 126.98K |
| Oct 5, 2026 | $18.81 | $20.03 | $18.74 | $19.60 | 148.09K |
| Oct 2, 2026 | $18.89 | $19.4899 | $18.545 | $19.01 | 144.35K |
| Oct 1, 2026 | $18.90 | $19.60 | $18.455 | $18.75 | 213.36K |
| Sep 30, 2026 | $18.84 | $19.50 | $18.44 | $18.90 | 191.19K |
| Sep 29, 2026 | $17.80 | $18.99 | $17.78 | $18.79 | 162.24K |
| Sep 28, 2026 | $16.95 | $18.3174 | $16.56 | $17.95 | 155.21K |
| Sep 25, 2026 | $17.08 | $17.43 | $16.81 | $16.99 | 77.09K |
| Sep 24, 2026 | $17.21 | $17.40 | $16.815 | $17.01 | 79.87K |
| Sep 23, 2026 | $17.64 | $18.05 | $17.00 | $17.37 | 97.91K |
| Sep 22, 2026 | $17.44 | $18.17 | $17.255 | $17.61 | 108.09K |
| Sep 21, 2026 | $18.42 | $18.69 | $17.0946 | $17.52 | 61.43K |
| Sep 18, 2026 | $17.78 | $18.66 | $17.625 | $18.16 | 622.09K |
| Sep 17, 2026 | $18.07 | $18.33 | $17.37 | $17.80 | 155.71K |
| Sep 16, 2026 | $17.95 | $18.33 | $17.75 | $17.89 | 84.75K |
| Sep 15, 2026 | $17.78 | $18.28 | $17.58 | $17.95 | 92.34K |
| Sep 14, 2026 | $18.59 | $19.225 | $18.22 | $18.35 | 91.23K |
| Sep 11, 2026 | $19.53 | $19.69 | $18.37 | $18.53 | 123.52K |
| Sep 10, 2026 | $19.64 | $20.45 | $19.09 | $19.11 | 79.91K |
| Sep 9, 2026 | $19.90 | $20.285 | $19.52 | $19.64 | 102.54K |
| Sep 8, 2026 | $20.22 | $20.41 | $19.66 | $19.99 | 98.77K |
The latest Smart Investors Daily articles mentioning SI.
Company
Market Activity
Research & News
SI research
Company profile and research snapshot.
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 10, 2026 | UBS | Buy | — |
| Aug 7, 2026 | Piper Sandler | Overweight | — |
| Aug 7, 2026 | BTIG | Buy | — |
| Jul 28, 2026 | UBS | Buy | — |
| May 8, 2026 | Piper Sandler | Overweight | — |
No generated briefing is available yet.
SeekingAlpha · Sep 16, 2026
Shoulder Innovations, Inc. (SI) Morgan Stanley 24th Annual Global Healthcare Conference September 15, 2026 3:20 PM EDTCompany ParticipantsRobert Ball -...
Yahoo · Sep 10, 2026
Shoulder Innovations, Inc. ("Shoulder Innovations", or "the company") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the N-22 Humeral Head, a titanium implant option for patients with metal hypersensitivity. Alongside the clearance, the company also announced the product's full commercial launch.
Benzinga · Sep 10, 2026
Shoulder Innovations, Inc. ("Shoulder Innovations", or "the company") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market,
Yahoo · Sep 9, 2026
Shoulder Innovations, Inc. ("Shoulder Innovations", or "the company") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it has entered into an exclusive collaboration with ALM Ortho, Inc. ("ALM Ortho"), a leader in additive manufacturing of titanium orthopedic implants, to introduce a bespoke implant for the treatment of severe shoulder deformity and other highly complex revision cases, circumstances f
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning SI.
